Skip to main content
Premium Trial:

Request an Annual Quote

BGI Partners with PentaBase to Develop PCR-Based Dx Kits

NEW YORK (GenomeWeb News) – The Beijing Genome Institute and the Danish diagnostic developer PentaBase have agreed to co-develop disease detection kits using genetic biomarkers, PentaBase said today.
 
The agreement expands an ongoing collaboration with SD Genomics, which serves as BGI’s contact point in Denmark, that is focused on developing and launching real-time PCR-based diagnostics kits.
 
PentaBase sells primers and probes for real-time PCR applications, while BGI is a genetic sequencing center with more than 120 sequencing machines, 10 supercomputers, and 500 terabytes of storage, the companies said in a statement.
 
Terms of the alliance were not disclosed.

The Scan

Removal Inquiry

The Wall Street Journal reports that US lawmakers are seeking additional information about the request to remove SARS-CoV-2 sequence data from a database run by the National Institutes of Health.

Likely to End in Spring

Free lateral flow testing for SARS-CoV-2 may end in the UK by next spring, the head of Innova Medical Group says, according to the Financial Times.

Searching for More Codes

NPR reports that the US Department of Justice has accused an insurance and a data mining company of fraud.

Genome Biology Papers on GWAS Fine-Mapping Method, COVID-19 Susceptibility, Rheumatoid Arthritis

In Genome Biology this week: integrative fine-mapping approach, analysis of locus linked to COVID-19 susceptibility and severity, and more.